Piperacillin

BRAND NAMES

• Zosyn (piperacillin + tazobactam)

• Pipracillin (various generics)

• Pipracil

MECHANISM OF ACTION

Piperacillin is a beta-lactam antibiotic that works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), blocking the cross-linking of peptidoglycan chains, which weakens the cell wall and leads to bacterial cell lysis and death. It is bactericidal and is especially effective against a broad range of Gram-negative organisms, including Pseudomonas aeruginosa.

PHARMACOKINETICS

Absorption

Piperacillin is a beta-lactam antibiotic that works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), blocking the cross-linking of peptidoglycan chains, which weakens the cell wall and leads to bacterial cell lysis and death. It is bactericidal and is especially effective against a broad range of Gram-negative organisms, including Pseudomonas aeruginosa.

Distribution

Piperacillin is widely distributed in body tissues and fluids after administration, including the lungs, bile, peritoneal fluid, and urinary tract. It has moderate protein binding (about 20–30%), which allows good tissue penetration. It does not readily cross the blood–brain barrier unless the meninges are inflamed. Its broad distribution supports its use in treating systemic and deep-seated infections.

Metabolism

Piperacillin undergoes minimal metabolism in the body and is largely excreted unchanged. A small portion may be converted to inactive metabolites, but hepatic metabolism is not a major pathway. Its pharmacologic activity is mainly due to the unchanged drug circulating in the bloodstream.

Elimination

Piperacillin is eliminated primarily by the kidneys through glomerular filtration and tubular secretion, with most of the drug excreted unchanged in urine. It has a relatively short half-life, so dose adjustment is required in patients with renal impairment. A small portion is excreted in bile. Continuous or repeated dosing is often needed to maintain effective therapeutic levels.

PHARMACODYNAMICS

Piperacillin is a time-dependent bactericidal antibiotic whose activity depends on the duration that drug concentrations remain above the minimum inhibitory concentration (MIC). It binds to penicillin-binding proteins (PBPs), inhibiting bacterial cell wall synthesis and leading to cell lysis and death. It has a broad spectrum of activity, particularly against Gram-negative organisms including Pseudomonas aeruginosa, and is often enhanced when combined with tazobactam, which inhibits beta-lactamase enzymes and prevents drug degradation.

ADMINISTRATION

Piperacillin is administered only by intravenous (IV) or intramuscular (IM) injection, as it is not absorbed orally. In clinical practice, it is most commonly given as an IV infusion, especially in hospital settings for severe infections. When combined with tazobactam, it is typically infused over 30 minutes or given as an extended infusion to maintain effective drug levels. Dosage and frequency depend on the type and severity of infection and renal function.

DOSAGE AND STRENGTH

Piperacillin, commonly used in combination with tazobactam, is administered intravenously in adult patients at doses such as 3.375 g every 6 hours or 4.5 g every 6–8 hours, depending on the severity and type of infection. In more severe conditions like sepsis or hospital-acquired infections, higher doses or extended infusion regimens may be used to maintain effective drug levels. The dosage must be adjusted in patients with renal impairment to prevent accumulation and toxicity. Piperacillin/tazobactam is available in IV vial strengths of 2.25 g, 3.375 g, and 4.5 g, allowing flexible dosing based on clinical requirements.

DRUG INTERACTIONS

Piperacillin may interact with several drugs, especially those affecting renal function or blood clotting. When used with aminoglycosides, it may show synergistic antibacterial effects but should not be mixed in the same IV solution due to incompatibility. It can increase the risk of bleeding when combined with anticoagulants like warfarin. Probenecid can reduce renal excretion of piperacillin, increasing its levels and effects.

CONTRAINDICATIONS

Piperacillin is contraindicated in patients with known hypersensitivity to piperacillin, other penicillins, or beta-lactam antibiotics such as cephalosporins (due to possible cross-reactivity). It should not be used in individuals with a history of severe allergic reactions like anaphylaxis to penicillins. Caution is also required in patients with a history of severe drug-induced skin reactions or hypersensitivity syndromes.

SIDE EFFECTS

• Diarrhea 

• Nausea and vomiting 

• Rash 

• Allergic reactions (urticaria) 

• Injection site pain 

• Thrombophlebitis 

• Fever 

• Elevated liver enzymes 

• Eosinophilia

OVER DOSAGE

Piperacillin overdose may lead to neuromuscular excitability or seizures, especially in patients with renal impairment due to drug accumulation. Other possible effects include electrolyte imbalance, bleeding tendencies, and gastrointestinal disturbances.

TOXICITY

Piperacillin toxicity is uncommon but may occur with high doses or in patients with renal impairment due to drug accumulation. It can lead to neurological effects such as seizures or encephalopathy, gastrointestinal symptoms, electrolyte disturbances, and hematologic effects like bleeding tendency or cytopenias.